FDA approves tocilizumab trial for severe COVID-19.......

870 Views | 1 Replies | Last: 5 yr ago by jagvocate
Marcus Aurelius
How long do you want to ignore this user?
AG
https://www.pmlive.com/pharma_news/fda_approves_roches_actemra_covid-19_trial_1329887

SIAP.

As has been discussed on here, IL-6 has been shown, among other inflammatory mediators, to drive the "cytokine storm" in the dramatic ARDS decline phase of severe COVID-19 infection. I have witnessed this first hand for the first time and can say it is one of those humbling experiences in medicine. Nothing currently can save these poor people once it gets to this stage. This drug is approved in China. It is being used off label here. It is an IL-6 inhibitor used for RA and temporal arteritis.
Copperpot
How long do you want to ignore this user?
AG
Fingers crossed.
jagvocate
How long do you want to ignore this user?
AG
I know y'all are doing everything you can. I just wish we as a nation were more on top of this.

Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.